The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy

Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial

(2022) Ji Man Hong et al.   STROKE

Excitotoxicity: Still Hammering the Ischemic Brain in 2020

(2020) Dennis W. Choi   Frontiers in Neuroscience

Targeting NMDA receptors in stroke: new hope in neuroprotection

(2018) Qiu Jing Wu et al.   Molecular Brain

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

(2016) Mayank Goyal et al.   LANCET

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke

(2015) Tudor G. Jovin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

(2015) Jeffrey L. Saver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

(2015) Mayank Goyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

(2015) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion

(2012) Doo Soon Im et al.   BRAIN RESEARCH

Neuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside

(2012) Brad A. Sutherland et al.   International Journal of Stroke

Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage

(2012) Nishant P. Visavadiya et al.   TOXICOLOGY IN VITRO

Barthel Index for Stroke Trials

(2011) Terence J. Quinn et al.   STROKE

Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat

(2010) Ui Jin Park et al.   ACTA NEUROPATHOLOGICA

Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke

(2010) S.J. Cho et al.   DRUG NEWS & PERSPECTIVES

The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons

(2009) Jihyun Noh et al.   JOURNAL OF NEUROCHEMISTRY